Found 0 matching trials
Growth Hormone as a Model for Reversible Activation of Adipose Tissue Fibrosis
NABackground: Adipose tissue fibrosis denotes excessive pathological accumula...
Location
Aarhus University
Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients
PHASE3The main aim of this study is to assess the efficacy of the co-administrati...
Location
University Hospital, Charles University
Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly
N/ATo test the hypothesis that both lack and excess of growth hormone (GH) is ...
Location
Multiple Locations
Long Term Study With B2036-PEG
PHASE3Primary objective: To investigate the efficacy and safety of Pegvisomant in...
Location
Pfizer Investigational Site
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
PHASE1This is a Phase 1 study investigating the safety and tolerability of Figitu...
Location
Pfizer Investigational Site
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
PHASE4The purpose of the study is to determine if Pegvisomant is more efficacious...
Location
Pfizer Investigational Site
Canadian Pegvisomant Compassionate Study In Acromegalic Patients
PHASE4The purposes of this study are: 1) to provide SOMAVERT for compassionate us...
Location
Pfizer Investigational Site
Non Interventional Study For Patients Treated With Somavert®
N/AThis open-label, national, prospective, observational, non-interventional, ...
Location
Multiple Locations
PegvisOMant and the Immune SystEm (PROMISE)
N/AThis is a prospective observational pilot study for the evaluation of immun...
Location
Department of Experimental Medicine, "Sapienza" University of Rome
Strict IGF-1 Control in Acromegaly
PHASE3Acromegaly is a rare, chronic, and debilitating disease, usually caused by ...
Location
University of Alberta Hospital